Nutra Pharma Corp., a biotechnology company that has developed treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN), and Pain, has announced that it will bring on LWR Partners, an outside branding and marketing firm, to aid in the promotion, branding, and distribution of Nyloxin™, a clinically approved over-the-counter pain reliever.
Nyloxin™ is offered in two formulas. The standard formula, proven to treat moderate to severe chronic pain, and an extra strength formula, for more advanced chronic pain.
“We are excited to be working with LWR Partners to begin our first real marketing efforts for Nyloxin,” stated Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “While the Nyloxin products have been available for over a year, sales have been slow as the Company has depended on third-party sales and distributors to get the word out. We are now starting a campaign to have a unified brand strategy and appropriate marketing in our attempt to move sales up consistently both in the United States and abroad,” he concluded.
LWR Partners / “Brands To Market”™ is an elite group of branding, advertising, and media deployment experts that excels in maximizing the value of a company’s brand. LWR connects brands to customers through a variety of digital products including Social Media, Web Advertising, and Point of Decision media. Some of LWR Partners past branding successes include The Die Hard Battery, Taster’s Choice Coffee, and Jimmy Dean Sausage. Current clients range from ABA Basketball to The “Seeds of Freedom” Foundation, as well as The Commerce Science Corporation and many new top quality Brands.
James Warble, CEO of LWR Partners, commented, “The Nyloxin products represent a wonderful marketing opportunity. These are pain-relievers and anti-inflammatory drugs that have provided great results with almost no risk of side effects. The only thing missing is a branding and marketing strategy to let the world know about the power of these products,” he continued. “LWR will begin an aggressive campaign of digital marketing that includes audio, video, social media, internet banners and sales through more than 10,000 affiliated websites. This will allow the opportunity for sustainable sales growth while building a uniform branding strategy for the products.”
For more information, visit Nutra Pharma’s Web site at www.NutraPharma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment